Cue Biopharma, Inc. (CUE)

Cue Biopharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	27.49	22.46	48.51	51.61	64.37	74.87
Short-Term Investments	0.47	0.93	0.29	24.68	-	10
Cash & Short-Term Investments	27.96	23.39	48.8	76.29	64.37	84.87
Cash Growth	-6.88%	-52.08%	-36.03%	18.52%	-24.15%	42.85%
Receivables	0.53	0.95	1.7	0.06	3.14	1.42
Prepaid Expenses	2.35	0.81	0.96	0.84	0.87	1.24
Other Current Assets	-	-	-	-	0.08	-
Total Current Assets	30.84	25.14	51.45	77.19	68.47	87.53
Property, Plant & Equipment	5.57	4.84	7.12	10.7	11.92	8.88
Other Long-Term Assets	4.29	2.21	2.96	3.39	3.01	3.12
Total Assets	40.71	32.19	61.53	91.28	83.4	99.53
Accounts Payable	3.63	2.82	3.5	2.73	2.59	2.07
Accrued Expenses	1.52	2.91	4.14	3.55	4.62	2.79
Current Portion of Long-Term Debt	2.42	4.33	3.96	1.96	-	-
Current Portion of Leases	2.11	3.54	3.37	3.3	4.93	4.78
Current Unearned Revenue	9.58	0.09	2.11	-	0.65	6.68
Other Current Liabilities	-	-	-	-	0	-
Total Current Liabilities	19.25	13.69	17.08	11.55	12.79	16.32
Long-Term Debt	-	-	4.2	8.04	-	-
Long-Term Leases	3.1	1	3.16	6.02	5.12	2.37
Long-Term Unearned Revenue	-	-	-	-	-	1.94
Other Long-Term Liabilities	0.19	-	-	-	-	-
Total Liabilities	22.55	14.69	24.45	25.6	17.91	20.62
Common Stock	0.08	0.06	0.05	0.04	0.03	0.03
Additional Paid-In Capital	380.69	359.3	338.23	316.19	262.91	232.16
Retained Earnings	-362.6	-341.86	-301.19	-250.46	-197.45	-153.29
Comprehensive Income & Other	-	-	-	-0.1	-	0.01
Shareholders' Equity	18.16	17.5	37.09	65.68	65.49	78.91
Total Liabilities & Equity	40.71	32.19	61.53	91.28	83.4	99.53
Total Debt	7.63	8.88	14.7	19.32	10.05	7.15
Net Cash (Debt)	20.33	14.51	34.11	56.97	54.32	77.72
Net Cash Growth	8.32%	-57.45%	-40.14%	4.89%	-30.11%	44.97%
Net Cash Per Share	0.28	0.26	0.75	1.60	1.74	2.71
Filing Date Shares Outstanding	76.85	61.82	48.64	43.17	33.01	30.46
Total Common Shares Outstanding	76.45	61.82	47.22	43.04	32.2	30.35
Working Capital	11.59	11.45	34.37	65.64	55.68	71.21
Book Value Per Share	0.24	0.28	0.79	1.53	2.03	2.60
Tangible Book Value	18.16	17.5	37.09	65.68	65.49	78.91
Tangible Book Value Per Share	0.24	0.28	0.79	1.53	2.03	2.60
Machinery	4.21	4.03	4.29	5.62	5.55	4.51
Construction In Progress	-	-	-	-	-	0.41
Leasehold Improvements	0.12	0.12	0.12	0.12	0.01	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q